Gabapentin use and a claim for memory loss in Georgia

Georgia's gabapentin prescribing landscape reflects a stark urban-rural divide: metropolitan Atlanta has extensive specialist resources but rural south Georgia and the Savannah region face chronic pain management challenges that drive heavy gabapentin reliance. The state's large African American population faces compounded risks, as studies show that Black patients are more likely to be prescribed gabapentin for conditions where opioids would be withheld due to racial bias in pain management. Georgia has not scheduled gabapentin as a controlled substance, though the state's PDMP tracks dispensing. Fulton County (Atlanta) courts are plaintiff-favorable for pharmaceutical cases, while the Northern District of Georgia has an active pharmaceutical litigation docket.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Georgia.